AKT1 and pulmonary fibrosis: Recently, the PI3K/AKT signalling pathway was implicated as a master regulator for idiopathic pulmonary fibrosis, a disease with an autoimmune aetiology, characterized by a chronic progressive interstitial fibrosis [109,110].